These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


372 related items for PubMed ID: 15513382

  • 1. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds.
    Kronborg O, Jørgensen OD, Fenger C, Rasmussen M.
    Scand J Gastroenterol; 2004 Sep; 39(9):846-51. PubMed ID: 15513382
    [Abstract] [Full Text] [Related]

  • 2. [Randomized population study of screening for intestinal cancer with Hemoccult-II].
    Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O.
    Ugeskr Laeger; 1997 Aug 11; 159(33):4977-81. PubMed ID: 9281212
    [Abstract] [Full Text] [Related]

  • 3. A population-based estimate of the extent of colorectal cancer screening in Ontario.
    Rabeneck L, Paszat LF.
    Am J Gastroenterol; 2004 Jun 11; 99(6):1141-4. PubMed ID: 15180738
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic yield in a biennial Hemoccult-II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult-II.
    Rasmussen M, Fenger C, Kronborg O.
    Scand J Gastroenterol; 2003 Jan 11; 38(1):114-8. PubMed ID: 12608473
    [Abstract] [Full Text] [Related]

  • 5. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
    Yang KC, Liao CS, Chiu YH, Yen AM, Chen TH.
    J Med Screen; 2006 Jan 11; 13 Suppl 1():S8-13. PubMed ID: 17227635
    [Abstract] [Full Text] [Related]

  • 6. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
    Lindholm E, Brevinge H, Haglind E.
    Br J Surg; 2008 Aug 11; 95(8):1029-36. PubMed ID: 18563785
    [Abstract] [Full Text] [Related]

  • 7. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
    Chew MH, Suzanah N, Ho KS, Lim JF, Ooi BS, Tang CL, Eu KW.
    Singapore Med J; 2009 Apr 11; 50(4):348-53. PubMed ID: 19421676
    [Abstract] [Full Text] [Related]

  • 8. Randomised study of screening for colorectal cancer with faecal-occult-blood test.
    Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O.
    Lancet; 1996 Nov 30; 348(9040):1467-71. PubMed ID: 8942774
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of a selective screening for colorectal carcinoma: the Taiwan Multicenter Cancer Screening (TAMCAS) project.
    Chen TH, Yen MF, Lai MS, Koong SL, Wang CY, Wong JM, Prevost TC, Duffy SW.
    Cancer; 1999 Oct 01; 86(7):1116-28. PubMed ID: 10506694
    [Abstract] [Full Text] [Related]

  • 10. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].
    Trevisani L, Cifalà V, Sartori S, Tombesi P, Matarese V, Pezzoli A, Abbasciano V.
    Recenti Prog Med; 2009 Feb 01; 100(2):68-72. PubMed ID: 19350797
    [Abstract] [Full Text] [Related]

  • 11. Early detection of colorectal cancer with faecal occult blood test screening.
    Paimela H, Malila N, Palva T, Hakulinen T, Vertio H, Järvinen H.
    Br J Surg; 2010 Oct 01; 97(10):1567-71. PubMed ID: 20603855
    [Abstract] [Full Text] [Related]

  • 12. Colorectal cancer screening in the Czech Republic.
    Zavoral M.
    Z Gastroenterol; 2008 Apr 01; 46 Suppl 1():S29-30. PubMed ID: 18368637
    [Abstract] [Full Text] [Related]

  • 13. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
    Denters MJ, Deutekom M, Bossuyt PM, Stroobants AK, Fockens P, Dekker E.
    Gastroenterology; 2012 Mar 01; 142(3):497-504. PubMed ID: 22108194
    [Abstract] [Full Text] [Related]

  • 14. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
    Malila N, Oivanen T, Hakama M.
    Z Gastroenterol; 2008 Apr 01; 46 Suppl 1():S25-8. PubMed ID: 18368636
    [Abstract] [Full Text] [Related]

  • 15. Potential impact of population-based colorectal cancer screening in Canada.
    Flanagan WM, Le Petit C, Berthelot JM, White KJ, Coombs BA, Jones-McLean E.
    Chronic Dis Can; 2003 Apr 01; 24(4):81-8. PubMed ID: 14733756
    [Abstract] [Full Text] [Related]

  • 16. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E.
    Gastroenterology; 2008 Jul 01; 135(1):82-90. PubMed ID: 18482589
    [Abstract] [Full Text] [Related]

  • 17. [Features of colorectal cancer with fecal-occult-blood tests--comparison with colorectal cancer with no screening].
    Takemasa I, Kikkawa N, Yasui M, Nishisho I, Fujitani K, Mishima H, Hasuike Y, Kobayashi K.
    Gan To Kagaku Ryoho; 1998 Aug 01; 25(10):1514-8. PubMed ID: 9725042
    [Abstract] [Full Text] [Related]

  • 18. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
    Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Niv Y.
    Aliment Pharmacol Ther; 2006 Nov 15; 24(10):1475-81. PubMed ID: 17032281
    [Abstract] [Full Text] [Related]

  • 19. Population colorectal cancer screening with fecal occult blood test.
    Rennert G, Rennert HS, Miron E, Peterburg Y.
    Cancer Epidemiol Biomarkers Prev; 2001 Nov 15; 10(11):1165-8. PubMed ID: 11700264
    [Abstract] [Full Text] [Related]

  • 20. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
    Parente F, Marino B, DeVecchi N, Moretti R, Lecco Colorectal Cancer Screening Group, Ucci G, Tricomi P, Armellino A, Redaelli L, Bargiggia S, Cristofori E, Masala E, Tortorella F, Gattinoni A, Odinolfi F, Pirola ME.
    Br J Surg; 2009 May 15; 96(5):533-40. PubMed ID: 19358181
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.